Status:
ACTIVE_NOT_RECRUITING
Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy
Lead Sponsor:
Radboud University Medical Center
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Systemic chemotherapy can improve disease-related symptoms and/or prolong survival in patients with pancreatic cancer. Before the start of chemotherapy, the diagnosis pancreatic carcinoma must be conf...
Detailed Description
This study is an international multicenter prospective cohort study. The study will be performed in collaboration with the disciplines of Gastroenterology and Pathology of the participating hospitals.
Eligibility Criteria
Inclusion
- 18 years and older
- Clinical suspicion of pancreatic adenocarcinoma
- Indication for obtaining EUS-guided histology of a suspected pancreatic lesion
- Written informed consent
Exclusion
- Contra-indications to undergoing an EUS (e.g., oropharyngeal abnormalities)
- Altered anatomy (e.g., after previous Whipple-operation, Roux-and-Y gastrojejunostomy)
- Contra-indications to the administration of benzodiazepines, propophol or opioids
- Pregnancy
- Insufficient knowledge of the Dutch language to be able to understand the patient information
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05249075
Start Date
March 1 2022
End Date
December 1 2025
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA